Biomedical | Healthcare
Prof. Donato Zipeto at the University of Verona, Italy, invites scientists and physician-scientists around the world for a short-term certified fellowship in CRISPR/Cas9 Gene Editing Technology. Please refer your colleagues or interested students. This program is only available through Trialect's seizfire platform.
Program Details
Host: Prof. Donato Zipeto
Duration: 2 - 12 weeks
Application Deadline: Fast Approaching
Career Benefits of CRISPR/ CAS Technology
Leadership in Genetic Engineering
Pharmaceutical Innovation and Collaboration
Potential for Groundbreaking Discoveries
Career Advancement in Pharma: Amgen, Novartis, Gilead Sciences, Merck, and Pfizer are all active in this area.
Feedback
The training period, 2 weeks, was too short to accommodate all its components. It was a live, hands-on experience, and the group members in the hosting Lab helped me during the hands-on training. They were dedicated and willingly transferred all their skills to me within a limited period. Thanks a lot to the group.